Chemoinformaics analysis of 4-Methoxybenzophenone
| Molecular Weight | 212.248 | nRot | 3 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 13 |
| Exact Molecular Weight | 212.084 | nRing | 2 |
| Solubility: LogS | -3.787 | nHRing | 0 |
| Solubility: LogP | 3.147 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 32.9855 |
| nHD | 0 | BPOL | 14.6425 |
| QED | 0.731 |
| Synth | 1.254 |
| Natural Product Likeliness | -0.414 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.215 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.459 |
| MDCK | 0.0000217 |
| BBB | 0.245 |
| PPB | 0.98858 |
| VDSS | 0.769 |
| FU | 0.013561 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.92 |
| CYP2c19-sub | 0.124 |
| CYP2c9-inh | 0.809 |
| CYP2c9-sub | 0.871 |
| CYP2d6-inh | 0.092 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.284 |
| CYP3a4-sub | 0.459 |
| CL | 2.679 |
| T12 | 0.601 |
| hERG | 0.236 |
| Ames | 0.168 |
| ROA | 0.039 |
| SkinSen | 0.257 |
| Carcinogencity | 0.789 |
| EI | 0.971 |
| Respiratory | 0.115 |
| NR-Aromatase | 0.06 |
| Antiviral | No |
| Prediction | 0.712983 |